Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Benjamin Rioux-Masse"'
Publikováno v:
MedEdPORTAL, Vol 8 (2012)
Abstract Introduction This resource is a comprehensive curriculum of transfusion medicine with emphasis on acute hemolytic transfusion medicine and massive transfusion protocol. It includes scenarios located in various hospital settings (i.e., ward,
Externí odkaz:
https://doaj.org/article/89e1fdc2625a48ae8e4e5a3344dc92a3
Publikováno v:
MedEdPORTAL, Vol 7 (2011)
Abstract The scenario provides real-life training of acute hemolytic transfusion reaction (AHTR) in an anesthetized patient. Central to the experience is learners' ability to connect the hypotension and urine color change in an anesthetized patient t
Externí odkaz:
https://doaj.org/article/aba7f8f1ca40446591974ca19813b109
Publikováno v:
The Annals of pharmacotherapy. 51(12)
Autor:
Shanna, Morgan, Benjamin, Rioux-Masse, Cristina, Oancea, Claudia, Cohn, James, Harmon, Mojca, Konia
Publikováno v:
Transfusion. 55(4)
The administration of blood products is frequently determined by physicians without subspecialty training in transfusion medicine (TM). Education in TM is necessary for appropriate utilization of resources and maintaining patient safety. Our institut
Autor:
Claudia I Chapuy, Maria D Aguad, Rachel T Nicholson, James P AuBuchon, Claudia S Cohn, Meghan Delaney, Joan Cid, Walter Dzik, Mark K. Fung, Andreas Greinacher, Ai Leen Ang, Dana V. Devine, Nancy M Dunbar, Henk Garritsen, Lawrence T Goodnough, Ross Herron, Tor A. Hervig, C. Michael Knudson, Jose M Kutner, Frank Nizzi, Suchitra Pandey, Benjamin Rioux-Masse, Kathleen Selleng, Joseph Sweeney, Minoko Takanashi, Aaron A.R. Tobian, Lorna Wall, Silvano Wendel, David A Westerman, Meredith Unger, Parul Doshi, Michael F. Murphy, Larry J. Dumont, Richard M. Kaufman, The BEST Collaborative
Publikováno v:
Blood. 126:3567-3567
Introduction Daratumumab (DARA), an IgG1k human monoclonal antibody (Ab) against CD38, is a promising novel therapy for multiple myeloma. However, direct binding of DARA to endogenous CD38 on reagent red blood cells (RBCs) interferes with routine blo